Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03908385 · ClinicalTrials.gov registry record
Hemoglobin Desaturation in Sickle Cell Disease
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 1
- Enrollment target
NCT03908385: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT03908385 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03908385 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
As part of routine care for SCD, some people are found to have low oxygen levels (≤ 88%) while sleeping, at rest, or with exercise. Testing is done with a small portable device positioned on the finger that measures oxygen levels during sleep, at rest, or following exercise. The investigators start oxygen treatment for people with low levels of oxygen. As a part of this study, the investigators will find out if any changes in cell "stickiness" occur with low oxygen levels (at rest, at night, or with exertion) and if cells become "less sticky" with oxygen treatment. Study subjects will be seen before testing and 2 months after testing. In some cases (people with low oxygen levels during testing), study subjects will have been prescribed oxygen, and the investigators will test the effects of that treatment on the stickiness of red cells.
Primary Outcome
We will test resting SpO2 and night-time oxymetry to obtain Hb saturation results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-03-23 |
| Est. Completion | 2022-02-01 |
What the finished NCT03908385 record still lists
NCT03908385 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03908385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03908385 about?
NCT03908385 is a clinical study titled "Hemoglobin Desaturation in Sickle Cell Disease". As part of routine care for SCD, some people are found to have low oxygen levels (≤ 88%) while sleeping, at rest, or with exercise. Testing is done with a small portable device positioned on the finger that measures oxygen levels during sleep, at rest, or following exercise. The investigators start ...
What is the current status of trial NCT03908385?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-03-23. Estimated completion is 2022-02-01.
Who is sponsoring clinical trial NCT03908385?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI